ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02161679
Brief Title: Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer

First Submitted : June 10, 2014
First Submitted that Met QC Criteria : June 11, 2014
First Posted : June 12, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : October 9, 2015
Last Update Posted : October 12, 2015 (Estimate)